Gsk Share Discussion Threads

[mike24] 30/3/2015 07:05

great news for kids???? what about the 1000 that
will get meningitis b before vacine is introduced in sept,
of which one in ten of could die,

is it any wonder the coming election will be
influenced by votes against capitalism
and the chart looks weak, better buying ops for those
who wait, dyor

[zyzzyva] 29/3/2015 21:42

plenty of voting to be done on 7th may then

[philo124] 29/3/2015 18:02

No probs, I was wrong, it was meningitis B.

[nik rosa] 29/3/2015 17:40

Couldn't agree more Philo - just me putting my foot in it. Apologies all.
NR

[philo124] 29/3/2015 14:54

Great news for kids.

[nik rosa] 29/3/2015 14:28

Only great news if GSK didn't compromise too much on the price!
Monday's trading will reveal.
NR

[philo124] 29/3/2015 14:25

Great news re Hepatitis B Vaccines.

[sicker] 29/3/2015 13:55

No info as yet.
May hear more at AGM 7th May.

[zyzzyva] 29/3/2015 12:44

when is the £4bn special dividend happening?

[philanderer] 27/3/2015 23:54

'Even After Recent Gains, AstraZeneca plc And GlaxoSmithKline plc Are Still Cheap'

[philanderer] 27/3/2015 13:36

Ebola vaccine candidates pass safety test in Liberia trials

[philanderer] 26/3/2015 09:19

GlaxoSmithKline : Glaxo Gets Approval For Encruse Ellipta, Two Other Products In Japan

[madengland] 26/3/2015 08:57

I wonder how many sellers pre end tax year, who will turn buyers after April 6th?

[woodhawk] 25/3/2015 23:50

That quote doesn't make much sense does it? "They currently have a $42.00 price target on the stock. Zacks‘s price objective would indicate a potential downside of 11.30% from the company’s current price." How exactly is $42 LESS than the current price?!?

In any event that same article also says, further on:

"Seven analysts have rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $47.00."

[philanderer] 25/3/2015 23:09

Evening Woodhawk, nope not short , have never shorted a stock, just indices.

Long GSK from 1375p


'GlaxoSmithKline plc Stock Rating Reaffirmed by Zacks (GSK)'


GlaxoSmithKline plc (NYSE:GSK)‘s stock had its “hold” rating restated by Zacks in a research report issued on Wednesday. They currently have a $42.00 price target on the stock. Zacks‘s price objective would indicate a potential downside of 11.30% from the company’s current price.

Zacks’ analyst wrote, “Glaxo’s fourth-quarter results were disappointing with the company posting a year-over-year decline in both revenues and earnings. However, the company has resolved most of the supply issues that it was facing over the last few quarters. We are positive on Glaxo’s restructuring and divestment plans, which should make it more cost efficient. Moreover, Glaxo’s deal with Novartis should boost its consumer health business.

Meanwhile, challenges remain in the form of increasing competition, genericization and pricing pressure. Moreover, primary care contracting and pricing dynamics will continue to impact the performance of the respiratory segment.”

[jadeticl3] 25/3/2015 15:22

Analysts are the same as the weather forecaster--they know what will happen if all their assumptions are fulfilled. Of course when these are not, then they produce a new set of assumptions ad nauseum.
1350p!!!! They are a few weeks out of date are they not?

[woodhawk] 25/3/2015 12:40

That's a well-timed bit of doom there, philanderer, just as the share price threatens to drop below £16.00. You short?

[tradermichael] 25/3/2015 09:18

This kind of PR goes down much better in the US, even for a British company!

[cyberian] 25/3/2015 09:16

They should, and maybe they do although have not seen any evidence/publicity/statement to this effect.